IFNA1 and infection: In part because ZIKV NS5 effectively targets the interferon (IFN) signalling pathway in humans, but not in mice16, mice are less susceptible to infection, and immunocompetent adult mice replicate only low levels of viral RNA and develop no evidence of clinical disease15, 17.